🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

17 recruiting trials

for Renal Failure Chronic Requiring Dialysis

Activation of the Contact System and the Immune System in Patients With Chronic Kidney Disease. NCT05266092n/a1 site📍 Odense Odense University Hospital · Tests: Observational study Investigation of the Validity, Reliability, and Responsiveness of BETY-BQ in Chronic Kidney Disease, on Dialysis, and Kidney Transplantation NCT06591702n/a1 site📍 Ankara Hacettepe University · Tests: Questionnaire study Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System NCT04634916NA17 sites📍 La Jolla📍 San Francisco📍 Jacksonville C. R. Bard · Tests: EndoAVF Creation A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia NCT06712654Phase 231 sites📍 Huntsville📍 Chula Vista📍 Los Angeles R1 Therapeutics · Tests: AP306 75 mg BID, AP306 125 mg BID, AP306 150 mg BID, AP306 75 mg TID, AP306 100 mg TID Pumpkin Seed Oil as a Nutraceutical for Hemodialysis Patients NCT07710183NA1 site📍 Baghdad Al-Mustansiriyah University · Tests: Pumpkin Seed Oil 1000 mg, Standard hemodialysis care To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KN060 in ESRD Dialysis Patients NCT07201467Phase 1, Phase 21 site📍 Beijing Suzhou Alphamab Co., Ltd. · Tests: KN060 Bisacodyl Oral for Lowering Dysfunction (of Tenckhoff Catheter) NCT07351357Phase 46 sites📍 Kwai Chung📍 Sham Shui Po📍 Shatin Chinese University of Hong Kong · Tests: Bisacodyl 5 mg DIALysis With EXpanded Solute Removal NCT06660277NA3 sites📍 London📍 Orillia📍 Ottawa London Health Sciences Centre Research Institute OR Lawson … · Tests: Super High-Flux Dialyzer, High-Flux Dialyzer Integrating BIA and eGFR for Nutritional Status in Hemodialysis Patients NCT06873880n/a1 site📍 Tartu University of Tartu Predictive Value of Carotid Ultrasonography for Intradialytic Hypotension NCT07033260n/a1 site📍 Wuhu First Affiliated Hospital of Wannan Medical College · Tests: Non-invasive Monitoring New Biomarkers of Bone Mineral Metabolism as Cardiovascular Risk Factors in Chronic Kidney Disease Patients NCT02808572NA7 sites📍 Montpellier📍 Montpellier📍 Montpellier University Hospital, Montpellier · Tests: Plasma osteoprotegerin level, Plasma fibroblast growth factor 23 level, Vascular calcification score IMPACT OF DIALYSIS DURATION AND DIURESIS ON BLADDER CAPACITY AND COMPLIANCE IN END STAGE RENAL DISEASE PATIENTS AWAITING RENAL TRANSPLANT NCT07570771n/a1 site📍 Karachi Sindh Institute of Urology and Transplantation · Tests: Observational Assessment Impact Of Kidney Failure On The Regulation Of Humoral Response To Vaccination NCT06635525n/a3 sites📍 Milan📍 Milan📍 Milan Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Tests: Influenza vaccination, SARS-CoV-2 vaccine Incremental Hemodialysis for Veterans in the First Year of Dialysis (IncHVets) NCT05465044NA8 sites📍 Long Beach📍 West Los Angeles📍 West Haven VA Office of Research and Development · Tests: Twice-weekly hemodialysis with incremental crossover to thrice-weekly schedule, Thrice-Weekly Hemodialysis Pleth Variability Index for Predicting Low Blood Pressure During Maintenance Hemodialysis NCT07022847n/a1 site📍 Wuhu First Affiliated Hospital of Wannan Medical College · Tests: Non-invasive Monitoring Technology Assisted Collaborative Care Intervention to Improve Patient-centered Outcomes in Dialysis Patients NCT06978127NA2 sites📍 Albuquerque📍 Pittsburgh University of Pittsburgh · Tests: Technology Assisted Stepped Collaborative Care, Usual Care Arm Study to Compare the Outcome of Receiving Continued Immunosuppression Versus Stopping Immunosuppression at 6 Months to Safely Prevent Human Leukocyte Antigen (HLA) Sensitization in Patients With Late Renal Graft Failure NCT06676696Phase 41 site📍 Barcelona Hospital Universitari Vall d'Hebron Research Institute · Tests: Continue low dose calcineurin inhibitor (CNI), Calcineurin inhibitor withdrawal at 6 months
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy